JP5555891B2 - クモ毒から単離した新規ペプチド及びその使用 - Google Patents

クモ毒から単離した新規ペプチド及びその使用 Download PDF

Info

Publication number
JP5555891B2
JP5555891B2 JP2012528465A JP2012528465A JP5555891B2 JP 5555891 B2 JP5555891 B2 JP 5555891B2 JP 2012528465 A JP2012528465 A JP 2012528465A JP 2012528465 A JP2012528465 A JP 2012528465A JP 5555891 B2 JP5555891 B2 JP 5555891B2
Authority
JP
Japan
Prior art keywords
peptide
pain
seq
shows
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012528465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504318A (ja
JP2013504318A5 (enExample
Inventor
メイア，アロン
チェルキ，ロニト，シムチャ
コルブ，エラ
ラングット，ヤエル
バジャヨ，ニッシム
Original Assignee
アロモネ プリクリニカル リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アロモネ プリクリニカル リミテッド filed Critical アロモネ プリクリニカル リミテッド
Publication of JP2013504318A publication Critical patent/JP2013504318A/ja
Publication of JP2013504318A5 publication Critical patent/JP2013504318A5/ja
Application granted granted Critical
Publication of JP5555891B2 publication Critical patent/JP5555891B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Insects & Arthropods (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2012528465A 2009-09-15 2010-09-13 クモ毒から単離した新規ペプチド及びその使用 Expired - Fee Related JP5555891B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27233609P 2009-09-15 2009-09-15
US61/272,336 2009-09-15
PCT/IB2010/002275 WO2011033358A2 (en) 2009-09-15 2010-09-13 Novel peptides isolated from spider venom, and uses thereof

Publications (3)

Publication Number Publication Date
JP2013504318A JP2013504318A (ja) 2013-02-07
JP2013504318A5 JP2013504318A5 (enExample) 2013-10-17
JP5555891B2 true JP5555891B2 (ja) 2014-07-23

Family

ID=43731158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528465A Expired - Fee Related JP5555891B2 (ja) 2009-09-15 2010-09-13 クモ毒から単離した新規ペプチド及びその使用

Country Status (12)

Country Link
US (1) US8399026B2 (enExample)
EP (1) EP2504023B1 (enExample)
JP (1) JP5555891B2 (enExample)
CN (1) CN102573884B (enExample)
AR (1) AR078374A1 (enExample)
AU (1) AU2010296994B2 (enExample)
BR (1) BR112012005860A2 (enExample)
CA (1) CA2774350A1 (enExample)
IL (1) IL218382A0 (enExample)
MX (1) MX2012003078A (enExample)
SG (1) SG179101A1 (enExample)
WO (1) WO2011033358A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201601789TA (en) * 2011-03-16 2016-04-28 Amgen Inc Potent And Selective Inhibitors Of Nav1.3 And Nav1.7
WO2013026105A1 (en) * 2011-08-24 2013-02-28 The University Of Queensland Pest-controlling agents isolated from spider venom and uses thereof
EP2852397B1 (en) 2012-05-18 2022-02-16 Janssen Biotech, Inc. Huwentoxin-iv variants and methods of use
US9102751B2 (en) 2012-05-18 2015-08-11 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
US10414808B2 (en) 2012-05-18 2019-09-17 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
US9636418B2 (en) 2013-03-12 2017-05-02 Amgen Inc. Potent and selective inhibitors of NAV1.7
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
ES2841173T3 (es) 2013-10-03 2021-07-07 Janssen Biotech Inc Variantes de Protoxina-II y métodos de uso
GB201410108D0 (en) * 2014-06-06 2014-07-23 Univ Manchester Peptides, and methods and apparatus utilising same
MA41642A (fr) 2015-03-03 2018-01-09 Janssen Biotech Inc Variants de protoxine ii et méthodes d'utilisation
MX2017012654A (es) 2015-04-02 2018-01-09 Janssen Biotech Inc Variantes de protoxina-ii y metodos de uso.
CL2016002890A1 (es) * 2016-11-14 2017-06-30 Univ Antofagasta Peptidos con actividad antimicrobiana
CN107141343A (zh) * 2017-06-01 2017-09-08 长沙沁才生物科技有限公司 一种活性多肽spkp‑xi的制备方法
CN107141344A (zh) * 2017-06-01 2017-09-08 长沙沁才生物科技有限公司 一种新型天然活性多肽spkp‑xi
CN107163124A (zh) * 2017-06-22 2017-09-15 长沙沁才生物科技有限公司 SPNP‑IX在制备Nav1.3通道抑制剂中的应用
CN107496904B (zh) * 2017-09-21 2020-03-17 中南大学 多肽Lycosin-Ⅰ在制备抗炎和抗弓形虫药物中的应用
CN108047323B (zh) * 2017-12-20 2022-04-12 深圳羽众医药科技有限公司 一种固相片段法合成GpTx-1及其类似物和合成方法
US20230374084A1 (en) * 2020-09-23 2023-11-23 Aldevron, Llc Potent and selective inhibitors of nav1.7

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4675381A (en) 1983-07-01 1987-06-23 Battelle Memorial Institute Biodegradable polypeptide and its use for the gradual release of drugs
US5417986A (en) 1984-03-16 1995-05-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
CN1133461C (zh) * 2000-04-11 2004-01-07 厦门北大之路生物工程有限公司 虎纹捕鸟蜘蛛毒素提取物在制备镇痛药物中的应用
JP2004537253A (ja) * 2000-07-21 2004-12-16 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション ミュー−コノペプチド
EP1578787B1 (en) * 2002-12-02 2012-11-14 Xenome Ltd Novel chi-conotoxin peptides (-ii)

Also Published As

Publication number Publication date
AU2010296994A1 (en) 2012-04-19
US8399026B2 (en) 2013-03-19
JP2013504318A (ja) 2013-02-07
SG179101A1 (en) 2012-05-30
MX2012003078A (es) 2012-08-03
IL218382A0 (en) 2012-04-30
WO2011033358A2 (en) 2011-03-24
BR112012005860A2 (pt) 2017-01-31
EP2504023A4 (en) 2013-04-10
EP2504023A2 (en) 2012-10-03
CN102573884A (zh) 2012-07-11
WO2011033358A3 (en) 2011-07-14
AR078374A1 (es) 2011-11-02
CN102573884B (zh) 2015-01-14
CA2774350A1 (en) 2011-03-24
AU2010296994B2 (en) 2013-09-19
EP2504023B1 (en) 2015-07-15
US20110065647A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
JP5555891B2 (ja) クモ毒から単離した新規ペプチド及びその使用
JP6120782B2 (ja) インターロイキン−１受容体のアンタゴニスト
EP4014984A1 (en) Compositions for use in treating aging-associated conditions
JP5345929B2 (ja) 環状アルファ−コノトキシンペプチド
JP4212651B2 (ja) サソリ由来神経ペプチド
EP2212349B1 (en) Synthetic analogues of neural regeneration peptides
US9725484B2 (en) Methods and compositions for the treatment of bone remodeling disorders
KR20220117319A (ko) 레트로-인버소 펩타이드
EP1161951B1 (en) Selenocosmia huwena toxin and analgesic uses thereof
EA013565B1 (ru) Варианты полипептидов нейбластина, способы их получения и их применение
JP5746616B2 (ja) ペプチドトキシンＡＰＥＴｘ２の鎮痛作用
JP6897971B2 (ja) 関節炎を処置するための、方法および組成物
US10881712B2 (en) Neuroprotective agents derived from spider venom peptides
JP4565087B2 (ja) 新規なχ−コノトキシン・ペプチド（−Ｉ）
EP1765851B1 (en) Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
US9464121B2 (en) Compositions and methods for treating erectile dysfunction
JP5861215B2 (ja) 神経ペプチドを用いた神経因性疼痛軽減薬剤ならびに抗うつ薬剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130828

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130828

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20130829

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20130918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131001

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131224

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140401

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140422

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140509

R150 Certificate of patent or registration of utility model

Ref document number: 5555891

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees